Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan Blaney

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Breastfeeding Medicine : the Official Journal of the Academy of Breastfeeding Medicine|July 31, 2007
Early consumption of human milk oligosaccharides is inversely related to subsequent risk of respiratory and enteric disease in infantsMary Beth Flanders Stepans, Susan L Wilhelm, Melody Hertzog, et al.
Pediatric Blood & Cancer|November 20, 2013
Phase 1 trial of temsirolimus in combination with irinotecan and temozolomide in children, adolescents and young adults with relapsed or refractory solid tumors: a Children's Oncology Group StudyRochelle Bagatell, Robin Norris, Ashish M Ingle, et al.
Pediatric Blood & Cancer|August 20, 2005
Etoposide, vincristine, and cyclosporin A with standard-dose radiation therapy in newly diagnosed diffuse intrinsic brainstem gliomas: a pediatric oncology group phase I studyMark L Greenberg, Paul G Fisher, Carolyn Freeman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 16, 2004
Phase I trial of tirapazamine and cyclophosphamide in children with refractory solid tumors: a pediatric oncology group studyVictor M Aquino, Steve D Weitman, Naomi J Winick, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 12, 2004
Phenylbutyrate and phenylacetate induce differentiation and inhibit proliferation of human medulloblastoma cellsXiao-Nan Li, Suhag Parikh, Qin Shu, et al.
Pediatric Blood & Cancer|July 27, 2010
A phase II trial and pharmacokinetic study of oxaliplatin in children with refractory solid tumors: a Children's Oncology Group studyOrren Beaty, Stacey Berg, Susan Blaney, et al.
Journal of Pediatric Hematology/Oncology|July 27, 2002
Atypical teratoid/rhabdoid tumor of the central nervous system: report on workshopRoger J Packer, Jaclyn A Biegel, Susan Blaney, et al.
Neuro-Oncology|August 22, 2008
Motexafin gadolinium and involved field radiation therapy for intrinsic pontine glioma of childhood: a Children's Oncology Group phase I studyKristin A Bradley, Ian F Pollack, Joel M Reid, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2005
Atypical teratoid/rhabdoid tumors (ATRT): improved survival in children 3 years of age and older with radiation therapy and high-dose alkylator-based chemotherapyTanya M Tekautz, Christine E Fuller, Susan Blaney, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 29, 2017
Pediatric Phase I Trial and Pharmacokinetic Study of Trebananib in Relapsed Solid Tumors, Including Primary Tumors of the Central Nervous System ADVL1115: A Children's Oncology Group Phase I Consortium ReportSarah E S Leary, Julie R Park, Joel M Reid, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Breastfeeding Medicine : the Official Journal of the Academy of Breastfeeding Medicine|July 31, 2007
Early consumption of human milk oligosaccharides is inversely related to subsequent risk of respiratory and enteric disease in infantsMary Beth Flanders Stepans, Susan L Wilhelm, Melody Hertzog, et al.
Pediatric Blood & Cancer|November 20, 2013
Phase 1 trial of temsirolimus in combination with irinotecan and temozolomide in children, adolescents and young adults with relapsed or refractory solid tumors: a Children's Oncology Group StudyRochelle Bagatell, Robin Norris, Ashish M Ingle, et al.
Pediatric Blood & Cancer|August 20, 2005
Etoposide, vincristine, and cyclosporin A with standard-dose radiation therapy in newly diagnosed diffuse intrinsic brainstem gliomas: a pediatric oncology group phase I studyMark L Greenberg, Paul G Fisher, Carolyn Freeman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 16, 2004
Phase I trial of tirapazamine and cyclophosphamide in children with refractory solid tumors: a pediatric oncology group studyVictor M Aquino, Steve D Weitman, Naomi J Winick, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 12, 2004
Phenylbutyrate and phenylacetate induce differentiation and inhibit proliferation of human medulloblastoma cellsXiao-Nan Li, Suhag Parikh, Qin Shu, et al.
Pediatric Blood & Cancer|July 27, 2010
A phase II trial and pharmacokinetic study of oxaliplatin in children with refractory solid tumors: a Children's Oncology Group studyOrren Beaty, Stacey Berg, Susan Blaney, et al.
Journal of Pediatric Hematology/Oncology|July 27, 2002
Atypical teratoid/rhabdoid tumor of the central nervous system: report on workshopRoger J Packer, Jaclyn A Biegel, Susan Blaney, et al.
Neuro-Oncology|August 22, 2008
Motexafin gadolinium and involved field radiation therapy for intrinsic pontine glioma of childhood: a Children's Oncology Group phase I studyKristin A Bradley, Ian F Pollack, Joel M Reid, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2005
Atypical teratoid/rhabdoid tumors (ATRT): improved survival in children 3 years of age and older with radiation therapy and high-dose alkylator-based chemotherapyTanya M Tekautz, Christine E Fuller, Susan Blaney, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 29, 2017
Pediatric Phase I Trial and Pharmacokinetic Study of Trebananib in Relapsed Solid Tumors, Including Primary Tumors of the Central Nervous System ADVL1115: A Children's Oncology Group Phase I Consortium ReportSarah E S Leary, Julie R Park, Joel M Reid, et al.
Pageof 3